Urszula Cymerman

Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.

Nadia Pece, S Vera, Urszula Cymerman et al. · Journal of Clinical Investigation · 1997 · 156 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells.

Sylvie St‐Jacques, Urszula Cymerman, Nadia Pece et al. · Endocrinology · 1994 · 134 citations

Life Sciences, Biochemistry, Molecular Biology +7

Endoglin Expression Is Reduced in Normal Vessels but Still Detectable in Arteriovenous Malformations of Patients with Hereditary Hemorrhagic Telangiectasia Type 1

Annie Bourdeau, Urszula Cymerman, Marie-Ève Paquet et al. · American Journal Of Pathology · 2000 · 126 citations · Full text

Medicine, Molecular Medicine, Pathology +9

Expression Analysis of Four Endoglin Missense Mutations Suggests That Haploinsufficiency Is the Predominant Mechanism for Hereditary Hemorrhagic Telangiectasia Type 1

Nadia Pece-Barbara, Urszula Cymerman, S Vera et al. · Human Molecular Genetics · 1999 · 121 citations · Full text

Life Sciences, Genetics, Molecular Biology +8

Identification of Hereditary Hemorrhagic Telangiectasia Type 1 in Newborns by Protein Expression and Mutation Analysis of Endoglin

Urszula Cymerman, Sonia Vera, Nadia Pece-Barbara et al. · Pediatric Research · 2000 · 86 citations

Life Sciences, Genetics, Molecular Genetics +10